| Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy A Alqahtani, K Choucair, M Ashraf, DM Hammouda, A Alloghbi, T Khan, ... Future science OA 5 (3), FSO372, 2019 | 272 | 2019 |
| TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials K Choucair, S Morand, L Stanbery, G Edelman, L Dworkin, J Nemunaitis Cancer gene therapy 27 (12), 841-853, 2020 | 114 | 2020 |
| PTENgenomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity K Choucair, J Ejdelman, F Brimo, A Aprikian, S Chevalier, J Lapointe BMC cancer 12, 1-9, 2012 | 97 | 2012 |
| Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib J Nemunaitis, S Bauer, JY Blay, K Choucair, H Gelderblom, S George, ... Future Oncology 16 (1), 4251-4264, 2020 | 58 | 2020 |
| Natural killer cells: a review of biology, therapeutic potential and challenges in treatment of solid tumors K Choucair, JR Duff, CS Cassidy, MT Albrethsen, JD Kelso, A Lenhard, ... Future oncology 15 (26), 3053-3069, 2019 | 47 | 2019 |
| The 16p13. 3 (PDPK1) genomic gain in prostate cancer: a potential role in disease progression KA Choucair, KP Guérard, J Ejdelman, S Chevalier, M Yoshimoto, ... Translational oncology 5 (6), 453-460, 2012 | 47 | 2012 |
| PIK3CA gene aberrancy and role in targeted therapy of solid malignancies O Willis, K Choucair, A Alloghbi, L Stanbery, R Mowat, ... Cancer gene therapy 27 (9), 634-644, 2020 | 29 | 2020 |
| Traumatic brain injury, diabetic neuropathy and altered-psychiatric health: The fateful triangle H Abou-El-Hassan, B Dia, K Choucair, SA Eid, F Najdi, L Baki, F Talih, ... Medical hypotheses 108, 69-80, 2017 | 24 | 2017 |
| Chimeric antigen receptor T-cell therapy: reach to solid tumor experience MN Metzinger, C Verghese, DM Hamouda, A Lenhard, K Choucair, ... Oncology 97 (2), 59-74, 2019 | 22 | 2019 |
| Bifidobacterium spp: the promising Trojan Horse in the era of precision oncology N Ngo, K Choucair, JF Creeden, H Qaqish, K Bhavsar, C Murphy, K Lian, ... Future Oncology 15 (33), 3861-3876, 2019 | 20 | 2019 |
| Knowledge, perception, attitudes and behavior on influenza immunization and the determinants of vaccination K Choucair, J El Sawda, S Assaad, NG El Chakhtoura, H Hassouna, ... Journal of Epidemiology and Global Health 11 (1), 34-41, 2021 | 15 | 2021 |
| A case of acute heart failure following immunotherapy for metastatic lung cancer A Al-Obaidi, NA Parker, K Choucair, J Alderson, JM Deutsch Cureus 12 (5), 2020 | 10 | 2020 |
| Liquid biopsy-based precision therapy in patients with advanced solid tumors: a real-world experience from a community-based oncology practice K Choucair, BI Mattar, Q Van Truong, T Koeneke, P Van Truong, C Dakhil, ... The Oncologist 27 (3), 183-190, 2022 | 8 | 2022 |
| Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy. Future Sci OA. 2019; 5 (3): FSO372 A Alqahtani, K Choucair, M Ashraf, DM Hammouda, A Alloghbi, T Khan Epub 2019/03/25. https://doi. org/10.4155/fsoa-2018-0115 PMID: 30906568, 0 | 8 | |
| Clinical evaluation of ramucirumab for the treatment of hepatocellular carcinoma (HCC): place in therapy K Choucair, S Kamran, A Saeed OncoTargets and therapy, 5521-5532, 2021 | 7 | 2021 |
| Advances in immune therapies for the treatment of microsatellite instability‑high/deficient mismatch repair metastatic colorectal cancer K Choucair, M Radford, A Bansal, R Park, A Saeed International Journal of Oncology 59 (3), 1-17, 2021 | 7 | 2021 |
| Primary cutaneous diffuse large B-cell lymphoma, leg type: a case report A Al-Obaidi, NA Parker, K Choucair, D Lalich, P Truong Cureus 12 (6), 2020 | 6 | 2020 |
| Network based analysis identifies TP53m-BRCA1/2wt-homologous recombination proficient (HRP) population with enhanced susceptibility to Vigil immunotherapy E Sliheet, M Robinson, S Morand, K Choucair, D Willoughby, L Stanbery, ... Cancer Gene Therapy 29 (7), 993-1000, 2022 | 5 | 2022 |
| Pre-operative carboplatin/paclitaxel versus 5-fluorouracil (5-fu)-based chemoradiotherapy for older adults with esophageal cancer M Al-Jumayli, K Choucair, A Al-Obaidi, R Park, A Bansal, J Baranda, ... Anticancer Research 42 (1), 59-66, 2022 | 5 | 2022 |
| Solitary, late metastatic recurrence of renal cell carcinoma to the pancreas: A case report K Choucair, NA Parker, A Al-Obaidi, J Alderson, P Truong Cureus 12 (6), 2020 | 5 | 2020 |
Lance DworkinProfessor and Chair of Medicine, University of Toledo在 utoledo.edu 的电子邮件经过验证
